Long-Term Tolerability of Tocilizumab for the Treatment of Rheumatoid Arthritis

被引：0
|
作者：
Hishitani, Yoshihiro [1 ]
Hirano, Toru [1 ]
Shima, Yoshihito [1 ]
Ogata, Atsushi [1 ]
Narazaki, Masashi [1 ]
Hagihara, Keisuke [1 ]
Tanaka, Toshio [1 ]
机构：
[1] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan
来源：
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2243
引用
收藏
页码：S877 / S877
页数：1
相关论文
共 50 条
  • [41] Rofecoxib demonstrates long-term safety and tolerability in juvenile rheumatoid arthritis (JRA)
    Goodman, S
    Ferrandiz, M
    Kiss, MH
    Rose, ES
    Chen, PY
    Frontera, N
    Bolognese, JA
    Reicin, AS
    van Adelsberg, J
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S94 - S95
  • [42] LONG-TERM SAFETY OF TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS FOLLOWING A MEAN TREATMENT DURATION OF 3.9 YEARS (ENCORE)
    Genovese, M.
    Sebba, A.
    Youssef, P.
    Rischmueller, M.
    Jones, G.
    Rubbert-Roth, A.
    Scali, J.
    Alten, R.
    Kremer, J.
    Pitts, L.
    Rowell, L.
    Van Vollenhoven, R.
    INTERNAL MEDICINE JOURNAL, 2014, 44 : 25 - 25
  • [43] LONG-TERM SAFETY OF TOCILIZUMAB (TCZ) IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) AND A MEAN TREATMENT DURATION OF 3.7 YEARS
    Smith, M.
    Taylor, A.
    Youssef, P.
    Hall, S.
    Nash, P.
    Sebba, A.
    Rubbert-Roth, A.
    Scali, J.
    Alten, R.
    Kremer, J.
    Pitts, L.
    Van Vollenhoven, R.
    Genovese, M.
    INTERNAL MEDICINE JOURNAL, 2013, 43 : 33 - 33
  • [44] The efficacy and safety of reinstitution of tocilizumab in patients with relapsed active rheumatoid arthritis after long-term withdrawal of tocilizumab
    Sagawa, Akira
    MODERN RHEUMATOLOGY, 2011, 21 (04) : 352 - 358
  • [45] Long-Term Safety and Tolerability of Tocilizumab in Patients with a Mean Treatment Duration of 2.4 Years
    Van Vollenhoven, Ronald
    McCarthy, Tim
    Siri, Daniel
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (06) : 1299 - 1299
  • [46] LONG-TERM EXTENSION STUDIES OF TOCILIZUMAB IN RA: SAFETY AND TOLERABILITY
    Genovese, Mark C.
    Sebba, Anthony
    Rubbert-Roth, Andrea
    Scali, Juan
    Zilberstein, Moshe
    Vernon, Emma
    Vollenhoven, Ronald
    RHEUMATOLOGY, 2011, 50 : 33 - 33
  • [47] LONG-TERM EFFICACY OF TOCILIZUMAB UP TO 3.5 YEARS IN PATIENTS WITH RHEUMATOID ARTHRITIS: AN INTERIM ANALYSIS OF LONG-TERM EXTENSION STUDIES
    Calvo, A.
    Sid, D.
    Saavedra, M.
    Kissel, K.
    Alecock, E.
    Smolen, J.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S34 - S34
  • [48] Tocilizumab for the treatment of rheumatoid arthritis
    Mima, Toru
    Nishimoto, Norihiro
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2008, 4 (02) : 165 - 172
  • [49] Tocilizumab for the treatment of rheumatoid arthritis
    Tanaka, Toshio
    Ogata, Atsushi
    Narazaki, Masashi
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2010, 6 (06) : 843 - 854
  • [50] Successful peficitinib monotherapy for the new-onset skin manifestations of rheumatoid vasculitis after long-term treatment with tocilizumab for rheumatoid arthritis
    Oba, Yuki
    Sawa, Naoki
    Ikuma, Daisuke
    Mizuno, Hiroki
    Inoue, Noriko
    Sekine, Akinari
    Hasegawa, Eiko
    Yamanouchi, Masayuki
    Suwabe, Tatsuya
    Yamaguchi, Yuko
    Takasawa, Yutaka
    Ubara, Yoshifumi
    MODERN RHEUMATOLOGY CASE REPORTS, 2023, 8 (01) : 5 - 10
12345